Therefore, the identification of a promising biomarker for the prediction of immunotherapy response and prognosis in patients with HCC and the elucidating its potential role in the immune microenvironment of HCC is quite significant.
← all excerpts
A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma.
1
—
—